Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 35Other solid neoplasm 35Gynecologic 3Gastrointestinal 3Lymphoid 2Genitourinary 2Breast 2Sarcoma 1Myeloid 1Head & Neck 1Dermatologic 1

Conditions

Lymphoma 41Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 28Lymphoma, Follicular 21Lymphoma, Large-Cell, Immunoblastic 17Hodgkin Disease 16Lymphoma, Mantle-Cell 15Burkitt Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 9Recurrence 8Lymphoma, Large-Cell, Anaplastic 8Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Extranodal NK-T-Cell 4Immunoblastic Lymphadenopathy 4Neoplasm Metastasis 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Mesothelioma 2Lymphoma, T-Cell 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uveal Melanoma 1Sezary Syndrome 1Primary Myelofibrosis 1

Interventions

tazemetostat 2Pemetrexed 2Cisplatin 2ruxolitinib 1ribociclib 1belinostat 1avelumab 1abemaciclib 1Sirolimus 1Rifampin 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Midazolam 1Letrozole 1LY3023414 1Itraconazole 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Fulvestrant 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxepin 1Biological Therapy 14-(3-fluoropropyl)glutamic acid 1(4S)-4-(3-(18F)fluoropropyl)-L-glutamate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma × Cisplatin × Lymphoid × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

NCT01655225 2022-04-08

A Study of LY3023414 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
156 enrolled
BreastLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡